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Abstract
Objective: To test a method for performing electrical impedance myography (EIM) in the mouse hind limb for the
assessment of disease status in neuromuscular disease models.
Methods: An impedance measuring device consisting of a frame with electrodes embedded within an acrylic head was
developed. The head was rotatable such that data longitudinal and transverse to the major muscle fiber direction could be
obtained. EIM measurements were made with this device on 16 healthy mice and 14 amyotrophic lateral sclerosis (ALS)
animals. Repeatability was assessed in both groups.
Results: The technique was easy to perform and provided good repeatability in both healthy and ALS animals, with intra-
session repeatability (mean 6 SEM) of 5% 61% and 12% 62%, respectively. Significant differences between healthy and
ALS animals were also identified (e.g., longitudinal mean 50 kHz phase was 1860.6u for the healthy animals and 1461.0u for
the ALS animals, p = 0.0025).
Conclusions: With this simple device, the EIM data obtained is highly repeatable and can differentiate healthy from ALS
animals.
Significance: EIM can now be applied to mouse models of neuromuscular disease to assess disease status and the effects of
therapy.
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Introduction
Electrical impedance myography (EIM) is a technique in which
a high-frequency, low-intensity electrical current is applied via
surface electrodes to discrete areas of muscle and the resulting
voltages measured [1]. From these, the muscle’s electrical
characteristics, including its resistance, reactance, and phase are
calculated. Studies have shown the potential value of these EIM
values as biomarkers for assessing disease status and progression, in
amyotrophic lateral sclerosis [2], spinal muscular atrophy [3], and
myositis [4]; ongoing work suggests that it could also be potentially
useful as a diagnostic tool in helping to differentiate neuromus-
cular illness [5].
In addition to human studies, EIM has also been applied to rat
disease models [6–8]; such studies have been aimed at developing
a deeper knowledge of the relationship between EIM data and
underlying pathology. Perhaps more importantly, it can be used as
a tool to quickly evaluate drug efficacy during pre-clinical drug
development. In the rat, the technique has been performed on the
gastrocnemius muscle using a straightforward modification of the
human technique in which 4 discrete adhesive electrodes are
placed in a line on the skin overlying the muscle following the long
axis of the limb [6]. Excellent reproducibility can be achieved
using this simple approach.
For a variety of reasons, however, it would useful to be able to
study mouse neuromuscular disease models as well. Indeed, there
is an ever-increasing number of mouse models of neuromuscular
disease and a convenient, easily-applied, tool that does not require
animal sacrifice could find wide application. However, configuring
EIM for use in the mouse hind limb is not straightforward since
the mouse limb is considerably smaller than that of the rat (2 cm
circumference at mid calf for the mouse versus 6 cm for the rat)
and it is not possible simply to mimic the approach used in human
subjects using still smaller adhesive electrodes as was done in the
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rats. Moreover, it would be advantageous to also measure
electrical current flow in multiple directions, so as to assess the
muscle’s electrical anisotropy. Such measurements may provide
additional insight into muscle condition, including potentially
differentiating neurogenic from myopathic disease [5]. Although
such measurements were attempted previously using small metal
strips [9], the technique was very difficult to perform given the
mouse’s size.
Thus, in this study, we describe a new methodology for
performing EIM on the adult mouse hind limb using a fixed rigid
electrode array and provide results in both healthy animals and
those with ALS.
Methods
The Electrode Array
Figure 1 shows three different views of the device. Four stainless
steel strips placed in parallel were embedded within an acrylic
head, with each of the individual strips protruding slightly to help
ensure good contact with the skin. In particular, the electrode head
was an assembly of 5 flat laser-cut acrylic pieces and 4 flat water-
jet-cut stainless steel plates. The stainless steel plates were cut into
a stepped shape so they could be encased perpendicularly in the
stack of acrylic pieces, with their location entirely determined by
the location of mating slots in the acrylic pieces. The stainless steel
plates also had a zigzag pattern of notches around which a copper
wire was wound; the sharp edges of the notches ensured good
electrical contact with the copper wire, which connected to the
measurement equipment. The stainless steel plates were positioned
in the acrylic stack and permanently encased by adhering the
acrylic pieces together. Finally, the end of the stainless steel plates
that protruded slightly to serve as the contacting portion of the
electrode head was filed to remove any burrs or sharp edges. The
total footprint of the array was set at 3.95 by 6.85 mm, a
dimension based on measurements performed on the hind limbs of
multiple adult animals,. The two outer strips (to serve as current-
emitting electrodes) were 0.55 mm wide and 3.95 mm long; the
two inner strips (to serve as voltage-measuring electrodes) were
0.55 mm wide and 2.85 mm long. The strips were 0.55 mm apart
(measured from the center of each strip).
The head of the device was affixed to a rotatable arm that could
be placed squarely over the animal’s gastrocnemius muscle. The
rotatable arm included an embedded plastic disc with angle
markers allowing the array to be consistently placed relative to the
long axis of the limb. The electrode wires extended through the
center and out the top of the rotatable arm where they connected
Figure 1. Multiple views of the device. A. The entire device, showing the rotatable arm used to change the direction of the electrode array, the
angle marker, and the removable weights; B. A close-up view of the tetrapolar electrode array; C. the entire animal setup with the device overlying
the gastrocnemius muscle.
doi:10.1371/journal.pone.0045004.g001
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Figure 2. The test-retest and Bland-Altman plots of phase at 50 kHz for healthy and ALS mice in the longitudinal configuration. ICC
values are 0.94 for healthy mice and 0.93 for ALS mice.
doi:10.1371/journal.pone.0045004.g002
Table 1. Repeatability Analyses at 50 kHz.
Resistance (V) Reactance (V) Phase (6)
Long Trans Long Trans Long Trans
Normal ICC 0.90 0.88 0.95 0.89 0.94 0.88
Diff% ± SEM 5% 61% 6% 61% 7% 62% 10% 62% 5% 61% 7% 62%
Bias 4.0% 4.0% 2.2% 3.7% 21.7% 20.1%
Precision 5.0% 8.1% 8.7% 12.5% 6.0% 9.5%
ALS ICC 0.76 0.79 0.83 0.84 0.93 0.88
Diff% ± SEM 9% 62% 8% 62% 17% 64% 14% 64% 12% 62% 11% 63%
Bias 21.2% 1.3% 21.7% 21.0% 21.9% 21.5%
Precision 12.4% 9.2% 24.6% 19.4% 14.7% 13.3%
Long, longitudinal; trans, transverse.
doi:10.1371/journal.pone.0045004.t001
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to an impedance-measuring device. In addition, a dowel pin
extension parallel to the rotatable arm allowed for the addition of
weights to ensure consistent contact pressure of the device against
the muscle with each measurement.
Impedance Measurement System
EIM measurements were performed with the Imp SFB7H
bioimpedance spectroscopy device (ImpediMed, San Diego, CA).
This device could perform measurements over the 4 kHz to
1 MHz range within just several seconds. For the analyses that
follow, however, only values from 20 kHz to 500 kHz were
included.
Animals
8 male and 8 female healthy Swiss-Webster mice, obtained from
Charles River Laboratories, of 18 weeks of age were used for the
reproducibility studies. In addition, 7 male and 7 female ALS
SOD1 G93A animals (strain B6SJL-Tg(SOD1*G93A)1Gur/J),
bred from animals obtained from Jackson Laboratories were also
studied at 18 weeks of age. Animals were housed 5 per cage with
access to food ad libitum. All studies were approved by the Beth
Israel Deaconess Medical Center Institutional Animal Care and
Use Committee (IACUC).
Animal Measurement Procedures
All EIM measurements were performed with the animals placed
under 1% isoflurane anesthesia delivered by nosecone with a
heating pad underneath the limb to maintain consistent temper-
ature. After the fur was clipped, a depilatory agent was applied to
the skin to remove all remaining fur; the skin was then cleaned
with 0.9% saline solution. The leg was then taped to the measuring
surface at an approximately 45 degree angle extending out from
the body (Figure 1 C). To assist in repeat placement of electrodes,
a pinpoint tattoo was placed close to the center of the
gastrocnemius muscle at a point approximately 2/3 of the distance
between the midpoint of the lumbar spine and the base of the heel
pad of each mouse.
For assessment of electrical anisotropy (directional dependence
of electrical current flow through the tissue), the electrode array
was placed both parallel (i.e., 0u named longitudinal configuration)
and perpendicularly (i.e., 90unamed transverse configuration) to
the major muscle fiber direction by rotating the device arm.
For assessment of technique repeatability, after an initial set of
measurements was made, the animal was removed from the set-
up, lifted up, and then replaced about 1–2 minutes later and new
adhesive tape applied; the array was then placed on the leg and the
measurements repeated.
Figure 3. Major multifrequency EIM parameters (± SEM) for healthy and ALS mice in both longitudinal (06) and transverse
configurations (906).
doi:10.1371/journal.pone.0045004.g003
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Data Analysis
For assessment of immediate repeatability of the testing system
in all 16 healthy and 14 ALS mice, the percent variation between
measurements, intra-class correlation (ICC) coefficients, and
Bland-Altman analyses [10] were calculated. Comparisons
between normal and ALS animals were made using unpaired t-
test at selected frequencies. For all analyzes, significance was taken
at p,0.05, two tailed. The three major impedance parameters
included: the resistance, a measure of opposition to current flow;
the reactance, a measure of the ability of the tissue to briefly store
and release charge; and the phase, a ratio of these two basic
impedance parameters calculated via the relationship phase =
arctan (reactance/resistance). All three measures have demon-
strated potential value in clinical studies [1].
Results
Reproducibility of the Technique in Healthy and Normal
Mice at 50 kHz
Table 1 provides a summary of percent difference, intra-class
correlation values and Bland-Altman analyses of EIM measure-
ments at 50 kHz for both healthy and ALS mice at both
longitudinal and transverse configurations. Figure 2 provides a
graphical example of those data for phase values. As can be seen,
excellent reproducibility was achieved with this technique. For
example, for healthy mice, the percent difference of means (6
SEM) between the first and second set of measurements for phase
was just 5% 61% in longitudinal configuration and just 7% 62%
in transverse configuration.
Differences between Normal and ALS Animals
Figure 3 shows the multifrequency resistance, reactance, and
phase data averaged across the group of 18-week-old healthy mice
and the 18-week-old ALS mice in both longitudinal and transverse
positions. For the transverse measurements, data was only
obtained from 11 ALS mice since in 3 the atrophy was sufficiently
severe such that the electrode array could not fit entirely over the
muscle in the transverse direction. For both directions, resistance
decreases at higher frequencies for both healthy and ALS mice,
although the frequency dependence is greater in the healthy
animal. Both reactance and phase show a peak in the healthy
mouse; however the peaks are no longer present in the ALS
mouse. These changes in the multifrequency spectrum are similar
to those observed in human ALS [11] and in the previous rat [8].
Table 2 shows the data at selected frequencies with the associated
p values. Consistent with those previous studies, the differences
between healthy and diseased muscle was most apparent at
frequencies below 100 kHz. Of note, the reactance showed much
greater differences than the resistance at these frequencies. This
finding is consistent with the reactance’s being highly dependent
on the cumulative area of the muscle fiber membranes and the
consequent charge storage capability. In contrast, at these
frequencies, the resistance is mainly dependent on extracellular
water content and is thus less sensitive to the muscle fiber atrophy.
The transverse-longitudinal differences can also be summarized
by calculated a normalized anisotropy difference at each
Table 2. Longitudinal and Transverse EIM Data in Normal and
ALS Mice at Selected Frequencies.
Longitudinal
20 kHz 50 kHz 100 kHz 300 kHz 500 kHz
Resistance
(V)
Normal 34169.5 28266.4 23564.7 17963.4 16163.1
ALS 303610.6 26568.9 22968.6 17868.4 15768.1
p value 0.0112 0.1191 0.5354 0.8931 0.6673
Reactance
(V)
Normal 7964.4 9264.6 8864.0 7062.9 6563.0
ALS 4964.8 6664.9 7164.1 6863.1 6763.0
p value 0.0001 0.0007 0.0067 0.6117 0.6199
Phase (6) Normal 1360.4 1860.6 2060.6 2160.7 2260.9
ALS 960.8 1461.0 1761.1 2161.1 2461.2
p value 0.0002 0.0025 0.0248 0.9936 0.2787
Transverse
20 kHz 50 kHz 100 kHz 300 kHz 500 kHz
Resistance
(V)
Normal 410613.0 33369.9 26368.0 18166.1 15665.5
ALS 390619.7 338617.8 285616.9 201617.8 167619.2
p value 0.3930 0.7649 0.2135 0.2270 0.5205
Reactance
(V)
Normal 10265.5 12665.6 12464.7 9463.6 8263.7
ALS 6865.7 9667.4 10867.5 10568.3 10068.2
p value 0.0003 0.0034 0.0672 0.1903 0.0410
Phase (6) Normal 1460.5 2160.6 2560.6 2860.8 2861.1
ALS 1060.6 1661.1 2161.4 2862.6 3263.5
p value ,0.0001 0.0003 0.0049 0.7187 0.1865
doi:10.1371/journal.pone.0045004.t002
Figure 4. Normalized multifrequency anisotropy differences (± SEM) of all 3 major EIM parameters (resistance, reactance, phase)
for healthy and ALS mice.
doi:10.1371/journal.pone.0045004.g004
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frequency. This is completed by subtracting the longitudinal from
the transverse measurement at each frequency, divided by the
mean value at that frequency. The resulting multifrequency curves
for both the normal and ALS animals is plotted in Figure 4, which
differ substantially, paralleling previously multifrequency anisot-
ropy changes in seen in ALS patients [12].
Discussion
In this study we have developed and tested a relatively simple
device for performing EIM measurements on the calf of the mouse
hind limb. The device provides relatively good intra-session
reproducibility, both in healthy and in diseased animals, and can
also differentiate between the groups, greatly improving upon an
initial effort at obtaining these measurements [9]. Moreover, the
device is capable of performing measurements at both 0u and 90u
relative to the major muscle fiber direction.
The product used here was specifically designed and engineered
for this study and is not commercially available; however, if having
such a system were of sufficient general interest, it would be a
straightforward matter to create similar versions using this basic
design.
Although straightforward to perform, like any procedure, it did
take some practice to become fluid and consistent with its
application. It was critical to ensure that the array was sitting
precisely at the same angle when performing the measurements
and was clearly centered over the pinpoint tattoo. The moistening
of the animal’s skin with saline solution also needed to be
performed consistently by only applying a damp gauze pad
repeatedly to the limb. Finally, repeated application of the array
did cause irritation to the skin. Additional experience suggested
that the procedure should not be performed more than twice
weekly, lest irritation to the skin occur with secondary scabbing,
likely related to the repeat placement of the array and use of the
depilatory agent.
Several aspects of the results obtained here deserve further
discussion. First, the repeatability in normal animals was
somewhat better than that achieved in the advanced ALS animals.
Although the reasons for this are uncertain, several factors may
play a role including altered skin integrity in ALS [13], small limb
size (making the electrode array more sensitive to small differences
in placement), and lower impedance values for reactance and
phase, making identical absolute variations in parameters larger
when calculated as a percent. Second, the time between repeated
measurements was short and could not be expected to account for
other potential physiological variations to the measured imped-
ance, such as those due to exercise or hydration status, that could
contribute to reduced reproducibility in a real-world study. Third,
this study was only intended to introduce and evaluate the
reproducibility of the EIM technique in mice and was not meant
to assess EIM’s ability to monitor ALS progression in the SOD1
mouse model. In order to study this fully, it would be important to
compare EIM’s ability to monitor progression in mice with more
standard approaches such as measurement of body weight,
functional status, and motor unit number estimation. It does
remain possible, however, that EIM could specifically serve as a
potential replacement for the more challenging and time-
consuming technique of motor unit number estimation. Indeed,
the previous study in ALS rats suggested that EIM provided a
much more easily obtained, effective surrogate measure for motor
unit number estimation [8]. Whether this will also hold true in the
ALS mouse models remains to be determined.
At the frequencies of electrical current being applied here,
resistance mainly provides data on the extracellular milieu of the
muscle. For example, increasing endomysial fat will increase the
resistance values, whereas muscle edema would reduce it. The
reactance, in contrast, is mainly impacted by sarcolemmal surface
area and thus is especially sensitive to myocyte atrophy.
Accordingly, reactance shows the greatest alteration in denervat-
ing disorders where atrophy is most extreme. Since the phase is a
ratio of these two measures, it is a more non-specific parameter.
However, phase appears to be very sensitive in a variety of
contexts since myocyte atrophy is often accompanied by
alterations in the endomysium.
As suggested by this explanation of the EIM parameters, unlike
standard electromyography, in which the inherent electrical
activity of the muscles and nerves is measured, in EIM it is more
the histologic status of the tissue that is assessed. Accordingly,
EMG is best suited for showing situations in which resting
membrane potential stability and action potential morphology are
being altered such as in the evaluation of myotonic conditions or
nerve hyperexcitability. Standard needle EMG is also likely best
for evaluating conditions in which only selected muscles are
affected (e.g., due to an isolated nerve injury), since in EIM the
flow of electrical current cannot be confined to a single muscle. In
comparison, EIM is potentially useful in conditions in which the
alterations are histological and membrane stability and function is
thought to be stable, such as in disuse or muscle wasting, in which
EMG is typically normal, and in myopathies in which EMG
alterations can be very subtle. In most other conditions, however,
both EMG and EIM can be used, each offering something
different. For example, in ALS, EIM is very sensitive to alterations
in disease progression [14], whereas EMG is sensitive to disease
onset [15].
In summary, this approach provides a simple and reproducible
method for performing EIM in the mouse. Given the current and
expanding plethora of animal models of neuromuscular disease,
the ability to obtain rapid data on muscle condition may prove
valuable in a variety of contexts including assisting with the
identification of disease onset, disease severity, and monitoring the
effects of therapy. For example, it could serve a role in preclinical
drug testing such that the effect of therapy of muscular dystrophy
or motor neuron diseases could be assessed without animal
sacrifice and without performing time-consuming and often
inconsistent function tests. Moreover, this technology allows
further exploration of the relationship between different types of
muscle pathology and the surface impedance characteristics,
making it possible to expand further the application of EIM to
different disease models.
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